Stock listing
A2AS4N Stock Price, News, Filings & Events — Fulgent Genetics, Inc.
Selected listing: A2AS4N · LSX · EUR · DE
This page tracks Fulgent Genetics, Inc.'s A2AS4N:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AS4N:LSX. A2AS4N:LSX is the stock-level entry point for investors researching Fulgent Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fulgent Genetics, Inc. (ticker: FLGT) is a public company operating in the American market, with a market capitalization of approximately $558.6 million. The company specializes in genetic testing and related services, providing innovative solutions for healthcare providers and patients. Fulgent Genetics aims to enhance the understanding of genetic conditions through its advanced testing technologies.
- Ticker
- A2AS4N:LSX
- Asset type
- Stock
- Market cap
- $539.6M
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- LSX
- Currency
- EUR
Fulgent Genetics, Inc. A2AS4N:LSX stock context
This page tracks Fulgent Genetics, Inc.'s A2AS4N:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2AS4N:LSX. A2AS4N:LSX is the stock-level entry point for investors researching Fulgent Genetics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fulgent Genetics, Inc. (ticker: FLGT) is a public company operating in the American market, with a market capitalization of approximately $558.6 million. The company specializes in genetic testing and related services, providing innovative solutions for healthcare providers and patients. Fulgent Genetics aims to enhance the understanding of genetic conditions through its advanced testing technologies.
Latest news from Fulgent Genetics, Inc.
Fulgent Reports Second Quarter 2026 Financial Results
July 30, 2026
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 9, 2026
Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture
June 18, 2026
Fulgent Presents Updated FID-007 Data at ASCO 2026
June 1, 2026
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual ...
May 21, 2026
Fulgent Genetics, Inc. earnings calls
Fulgent Genetics, Inc. (FLGT) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Fulgent Genetics, Inc. (FLGT) Q1 2026 Earnings Call
May 1, 2026 · Replay with transcript and chapters
Fulgent Genetics, Inc. (FLGT) Q4 2025 Earnings Call
February 27, 2026 · Replay with transcript and chapters
Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call
November 7, 2025 · Replay with transcript and chapters
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call
August 1, 2025 · Replay with transcript and chapters
Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call
May 2, 2025 · Replay with transcript and chapters
Research Fulgent Genetics, Inc.
Fulgent Genetics, Inc. investor report
Review AI stock analysis and investor report context for A2AS4N:LSX.
Fulgent Genetics, Inc. company profile
View the public company page for Fulgent Genetics, Inc. on 6ix.
Fulgent Genetics, Inc. news
Read company news and market updates connected to Fulgent Genetics, Inc..
Fulgent Genetics, Inc. investor events
Find investor webinars, events, and replay context for Fulgent Genetics, Inc..
Alternate listings
FLGT:NASDAQ
US · USD
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
A2AS4N:LS
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
FLGT:BMV
MX · MXN
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
FLGT:BIVA
MX · MXN
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:GETTEX
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
FLGT:BOATS
US · USD
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:FWB
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:DUS
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:MUN
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:SWB
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.
7F0:TRADEGATE
DE · EUR
Alternate listing for Fulgent Genetics, Inc.; the primary context on this page is A2AS4N:LSX.